Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
3.190
-0.030 (-0.93%)
Jun 20, 2025, 11:46 AM - Market open
Omeros Employees
Omeros had 202 employees as of December 31, 2024. The number of employees increased by 4 or 2.02% compared to the previous year.
Employees
202
Change (1Y)
4
Growth (1Y)
2.02%
Revenue / Employee
n/a
Profits / Employee
-$757,876
Market Cap
186.91M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
OMER News
- 9 days ago - Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision - Benzinga
- 23 days ago - Omeros: On The Brink As It Awaits Its Fall PDUFA For A Potential Blockbuster - Seeking Alpha
- 24 days ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
- 5 weeks ago - Omeros Corporation (OMER) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 5 weeks ago - Omeros Corporation Reports First Quarter 2025 Financial Results - Business Wire
- 5 weeks ago - Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025 - Business Wire
- 5 weeks ago - Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026 - Business Wire
- 6 weeks ago - FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date - Business Wire